Opioid receptor ligands in human hepatic encephalopathy

Journal of Hepatology

Volumn 29, Issue 5, 1998, Pages 796-801

  Yurdaydin, Cihan ^a   Karavelioǧlu, Didem ^a   Onaran, Ongun ^a   Çelik, Turgay ^b   Yaşa, M Hadi ^a   Uzunalimoǧlu, Özden ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Beta endorphin; Human hepatic encephalopathy; Leu enkephalin; Met enkephalin

Indexed keywords

BETA ENDORPHIN; LEUCINE ENKEPHALIN; METENKEPHALIN; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CLEARANCE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

EID: 0032213574     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80261-4     Document Type: Article

References (28)

1. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. Br Med J. 297:1988;1501-1504.
2. Thornton JR, Losowsky MS. Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine. J Hepatol. 8:1989;53-59.
3. Yurdaydin C, Li Y, Ha J-H, Jones EA, Rothman R, Basile AS. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists. J Pharmacol Exp Ther. 273:1995;185-192.
4. De Waele J-P, Audet RM, Leong DK, Butterworth RF. Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain. Hepatology. 24:1996;895-901.
5. Bergasa NV, Jones EA. The pruritis of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology. 108:1995;1582-1588.
6. Thornton JR, Dean H, Losowsky MS. Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides? Gut. 29:1988;1167-1172.
7. Cooper JR, Bloom FE, Roth RH. Neuroactive peptides. 6th ed The Biochemical Basis of Neuropharmacology. 1991;381-427 Oxford University Press, New York.
8. Millan MJ, Herz A. The endocrinology of the opioids. Int Rev Neurobiol. 26:1985;1-83.
9. Basile AS, Jones EA, Skolnick P. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharm Rev. 42:1991;27-71.
10. Laidlaw J, Read AE, Sherlock S. Morphine tolerance in hepatic cirrhosis. Gastroenterology. 40:1961;389-396.
11. Conn HO, Lieberthal MM. The Hepatic Coma Syndromes and Lactulose. 1979;Williams & Wilkins Co. Baltimore.
12. Swain MG, Rothman RB, Xu H, Vergalla J, Bergasa NV, Jones EA. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology. 103:1992;630-635.
13. Duka T, Hollt V, Przewlocki R, Wesche D. Distribution of methionine and leucine enkephalin within the rat pituiary gland measured by highly specific radioimmuno-assays. Biochem Biophys Res Commun. 85:1978;1119-1127.
14. Guillemin R, Ling N, Vargo TM. Radioimmunoassay for alpha-endorphin and beta-endorphin. Biochem Biophys Res Comm. 77:1977;361-366.
15. Viveros OH, Diliberto EJ, Hazum E, Chang K-J. Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Mol Pharmacol. 16:1979;1101-1108.
16. Polak JM, Bloom SR, Sullivan SN, Facer P, Pearse AGE. Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet. i:1977;972-974.
17. Schultzberg M, Hokfelt T, Lundberg JM, Terenius L, Elfvin LG, Elde R. Enkephalin-like immunoreactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary glands. Acta Physiol Scand. 103:1978;475-477.
18. Bergasa NV, Sabol SL, Young WS, Kleiner DE, Jones EA. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol. 268:1995;346-354.
19. Swain MG, Heyes MP, Vergalla J, Jones EA. Methionine enkephalin accumulates in plasma but not in brain or cerebrospinal fluid of rats with acute toxic hepatitis. Neurosci Lett. 141:1992;243-246.
20. Bourgoin S, Artand F, Cesselin F, Glowinski J, Hamon M. Local and remote effects of intra-caudate administration of GABA-related drugs on met-enkephalin release in the basal ganglia. Brain Res. 361:1985;361-372.
21. 5-enkephalin level, precursor content and preproenkephalin messenger RNA abundance. J Pharmacol Exp Ther. 237:1986;326-331.
22. Harsing LG, Yang H-YT. Serotoninergic regulation of hypothalamic met-enkephalin content. Hannin I. Dynamics of Neurotransmitter Function. 1984;169-176 Raven Press, New York.
23. Yurdaydin C, Hörtnagl H, Steindl P, Zimmermann C, Pifl C, Singer EA, et al. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology. 12:1990;695-700.
24. Bergeron M, Reader TA, Pomier Layrargues G, Butterworth RF. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res. 14:1989;853-859.
25. Thornton JR, Losowsky MS. A role for the kidneys and liver in plasma beta-endorphin elimination? Clin Sci. 74:1988;51P. (Suppl. 18).
26. Millan MJ, Millan MH, Czlonkowski A, Höllt V, Pilcher CWT, Herz A, et al. A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis. J Neurosci. 4:1986;889-906.
27. Przewlocki R, Przewlocka B, Lason W, Garzón J, Stala L, Herz A. Opioid peptides, particularly dynorphin, and chronic pain. INSERM. 127:1984;159-170.
28. Przewlocki R, Lason W, Höllt V, Silberring J, Herz A. The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord. Brain Res. 413:1987;213-219.